References
- Miller J P., Farragher E B. Relapse of duodenal ulcer. Does it matter which drug is used in initial treatment?. Br Med J 1986; 293: 1117–8
- Dooley C P., Cohen H, Fitzgibbons P L., Bauer M, Appleman M D., Perez-Perez G I., et al. Prevalence of Helicobacter pylori infection and histological gastritis in asymptomatic persons. New Engl J Med 1989; 321: 1562–6
- Chamberlain C E., Peura D A. Campylobacter (Helicobacter) pylori: is peptic disease a bacterial infection?. Arch Intern Med 1990; 150: 951–5
- Coghlan J G., Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, et al. Campylobacter pylori and recurrence of duodenal ulcers–a 12 month follow-up study. Lancet 1987; 2: 1109–11
- Marshall B J., Goodwin C S., Warren J R., Murray R, Blincow E D., Blackbourn S J., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–12
- Borody T J., Cole P, Noonan S, Morgan A, Lenne J, Hyland L, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431–5
- Patchctt S, Beattie S, Leen E, Keane C, O'Morain C. Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 1992; 87: 24–7
- Tytgat G NJ, Graham D Y., Lee A, Marshall B J., Dixon M F., Axon A TR. Helicobacter pylori: causal agent in peptic ulcer disease?. J Gastroenterol Hepatol 1991; 6: 103–4
- Chiba N C., Rao B V., Rademaker J W., Hunt R H. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716–27
- Wilhelmsen I, Tangen Haug T., Berstad A, Ursin H. Increased relapse of duodenal ulcer in patients treated with cognitive psychotherapy. Lancet 1990; 336: 307
- Wilhelmsen I, Haug T T., Ursin H, Berstad A. Effect of short term cognitive psychotherapy on recurrence of duodenal ulcer: a prospective randomised trial. Psychosom Med 1994, In press
- Wilhelmsen I, Weberg R, Berstad K, Hausken T, Hundal O, Berstad A. Helicobacter pylori eradication with bismuth sub-nitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepatogastroenterology 1994; 41: 43–7
- Berstad K, Wilhelmsen I, Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992; 27: 977–83
- Bell G D., Weil J. Detection of Helicobacter pylori by the 14C-urea breath test. Helicobacter pylori and gastrointestinal disease. 2nd ed, B J. Rathbone, R V. Heatley. Blackwell, Oxford 1992; 74–87
- Veldhuyzen van Zanten S JO, Tytgat K MAJ, Hollingsworth J, Jalali S, Rashid F A., Bowen B M., et al. 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol 1990; 85: 399–403
- Ching C K. A simplified diagnostic approach to Helicobacter pylori infection–is it adequate [letter]?. Am J Gastroenterol 1991; 86: 1276–7
- Graham D Y., Klein P D., Evans D J., et al. Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin. Am J Gastroenterol 1991; 86: 1158–62
- Berstad K, Berstad A. Helicobacter pylori infection in peptic ulcer disease [review]. Scand J Gastroenterol 1993; 28: 561–7
- Derogatis L R., Lopez M C. PAIS and PAIS-SR. Administration. scoring and procedures manual. Johns Hopkins University School of Medicine, Baltimore 1983
- Derogatis L R. The Psychosocial Adjustment to Illness Scale (PAIS). J Psychosom Res 1986; 30: 77–91
- Greer S, Moorcy S, Baruch J DR, Watson M, Robertson B M., Mason A, et al. Adjuvant psychological therapy lot patients with cancer: a prospective randomised trial. Br Med J 1992; 304: 675–80
- Wilhelmsen I, Bakke A, Tangen Haug I, Endresen I M., Berstad A. Psychosocial Adjustment to Illness Scale (PAIS-SR) in a Norwegian material of patients with functional dyspepsia, duo denal ulcer and urinary bladder dysfunction. Clinical validation of the instrument. Scand J Gastroenterol 1994; 29, In press
- Nouris M J. SPSS/PC+ Statistics 4.0. SPSS Inc., Chicago 1990
- Graham D Y., Adam E, Klein P D., Evans D J., Hazell S L., Alpert L C., et al. Epidemiology of Campylobacter pylori infection. Gastroenterol Clin Biol 1989; 13: 84–9
- Nwokolo C U., Prewett E J., Sawyerr A M., Pounder R E. Lack of bismuth absorption from bismuth subnitrate (Roter) tablets. Eur J Gastroenterol 1990; 2: 433–5
- Lambert J R. Safety profile of bismuth-containing medications. Helicobacter pylori, gastritis and peptic ulcer, P Malfertheiner, H Ditschuneit. Springer-Verlag, Heidelberg 1990
- Dresow B, Fischer R, Gabbe E E., Wendel J, et al. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease. Scand J Gastroenterol 1992; 27: 333–6
- Goodwin C S., Worsley B. Peptic ulcer disease and helicobacter pylori infection. Curr Opin Gastroenterol 1992; 8: 122–7
- Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 2: 1233–5
- Adami H O., Bergstrøm R, Nyrèn O, Forhaug K, Gustavsson S, Løøf L, et al. Is duodenal ulcer really a psychosomatic disease? A population-based case-control study. Scand J Gastroenterol 1987; 22: 889–96
- Groen J J. Syndrome shift. Arch Intern Med 1964; 144: 113–7
- Alexander F. Psychosomatic medicine: its principles and applications. WW Norton, New York 1950
- Groen J J. The psychosomatic specificity hypothesis for the etiology of peptic ulcer. Psychother Psychosom 1971; 19: 295–309
- Holtmann G, Armstrong D, Poppel E, Bauerfeind A, Goebbel H, Arnold R, et al. Influence of stress on the healing and relapse of duodenal ulcers. Scand J Gastroenterol 1992; 27: 917–23